Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Implementation and Effectiveness of Intermittent Preventive Treatment for Malaria Using Dihydroartemisinin-piperaquine on Reducing Malaria Burden in School Aged Children in Tanzania

NCT04245033 is registered in ClinicalTrials.gov with National Institute for Medical Research, Tanzania as lead sponsor.

NCT NCT04245033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04245033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Implementation and Effectiveness of Intermittent Preventive Treatment for Malaria Using Dihydroartemisinin-piperaquine on Reducing Malaria Burden in School Aged Children in Tanzania
Lead sponsor
National Institute for Medical Research, Tanzania
Phase
Phase 4
Overall status
Completed
Start date
July 20, 2020
Completion date
June 28, 2021
Enrollment
4,100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria